How to Evaluate Peptide Quality: HPLC, Mass Spec, and Certificate of Analysis 101

A non-chemist guide to reading purity certificates and understanding what really matters

Most peptide buyers cannot evaluate the quality of what they receive. They rely on the supplier's marketing copy. This is the practical guide to reading the underlying chemistry, even if you don't have a chemistry background.

What you need to ask for

The minimum documentation a serious supplier provides:

• Certificate of Analysis (COA) with batch number and date
• HPLC chromatogram (visual proof of purity)
• Mass spectrum (proof the molecule matches the label)
• Counter-ion specification
• Sterility data if labeled for any human-relevant use
• Endotoxin testing for any injectable use case

If the supplier cannot or will not provide these, you cannot evaluate quality.

HPLC: the purity chromatogram

High-performance liquid chromatography separates compounds by their physicochemical properties. The output is a chromatogram — a graph with peaks. The main peptide peak is the largest. Impurity peaks are smaller, earlier or later in time.

What you're looking for:

• One dominant peak (the target peptide) representing ≥98% of total area
• Few minor peaks (<2% combined)
• UV detection at 220 nm (for peptide bond) and ideally 280 nm (for aromatic residues like Trp, Tyr, Phe)
• A reasonable retention time consistent with the peptide's hydrophobicity

What's a red flag:

• Multiple peaks of similar size (suggests impure synthesis)
• "Purity 95%" with no chromatogram shown
• The same chromatogram appearing across multiple suppliers (re-labeled material)
• No retention time, gradient method, or column specified

Mass spectrometry: identity confirmation

Mass spec measures the molecular weight of a compound. If the label says BPC-157 (1419 Da), the mass spec should show 1419 (or the exact monoisotopic mass with the relevant adducts). Without mass spec, "purity by HPLC" only tells you that one compound is present — not what compound.

The most useful mass spec data shows:

• The expected molecular ion peak [M+H]⁺ or relevant adducts
• Minimal fragmentation peaks at unexpected masses
• Consistency with the theoretical isotope pattern

If a peptide is labeled with a specific molecular formula and the mass spec doesn't match within ~1 Da, you have a different compound than the label claims.

Counter-ion: TFA vs acetate

Synthetic peptides usually carry a counter-ion (a charged molecule that pairs with the peptide's net charge). Common counter-ions are TFA (trifluoroacetic acid) from the synthesis process and acetate (preferred for human use).

TFA is concerning because it can persist in the final product and may cause local irritation. Acetate is the standard for clinical-grade peptides. A conscientious supplier specifies the counter-ion. A careless supplier doesn't.

If you cannot determine the counter-ion from the documentation, the safe assumption is TFA — and the safe behavior is to lower your expectation of clinical-grade quality.

Endotoxin: the most critical for injection

Bacterial endotoxins are lipopolysaccharide molecules from gram-negative bacterial cell walls. Even sterile peptide can contain endotoxin from the synthesis or purification process. Endotoxin causes fever, chills, and inflammation when injected.

The pharmaceutical limit for injectable peptides is generally below 5 EU/kg of body weight per dose. Translated practically: most clinical peptides are tested below 5 EU/mg.

Research-grade peptides are not always tested for endotoxin. If you cannot find an endotoxin number, you do not have an endotoxin-tested product.

Sterility: another injection essential

Sterility means the absence of viable microorganisms. It requires either terminal sterilization (heat, gamma irradiation) or aseptic processing. Vials must be sealed under sterile conditions. Sterility tests detect bacterial and fungal contamination.

Research-grade peptides are typically NOT sterile. They are intended to be reconstituted and used in lab conditions where sterility is not always relevant. For any human-relevant use, sterility documentation is essential.

Stability: how long it lasts

Peptides degrade over time. Common degradation pathways: oxidation (especially methionine, cysteine, tryptophan), deamidation (asparagine, glutamine), hydrolysis at certain bonds, aggregation in solution. Stability data tells you how long the labeled potency holds under stated storage conditions.

Most peptides are most stable as lyophilized powder at -20°C, less stable at 4°C, and rapidly degrading at room temperature in solution. A reputable supplier provides storage instructions and stability data.

The independent verification question

The strongest quality signal is independent third-party testing. Some labs (e.g., Janoshik Analytical) test peptide samples submitted by buyers and post results publicly. The presence of a peptide on community databases like /r/peptides Janoshik posts is a useful signal — the absence is just absence of testing, not necessarily absence of quality.

A serious quality position is: trust the supplier's COA but verify with independent testing for any compound you'll use chronically.

The practical position

Peptide quality is not visible from the outside. The vial looks the same whether the peptide is 99% pure or 80% pure with bacterial endotoxin. The only way to know is documentation — and the only way to verify documentation is independent testing.

For compounds you cannot independently verify, the conservative position is to assume research-grade quality with all that implies — variable purity, potential contamination, no sterility guarantees. That doesn't make use impossible, but it should change risk calibration.